共 50 条
- [1] Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium (Aurastop®) in the prophylaxis of episodic migraine without aura in a adult population JOURNAL OF HEADACHE AND PAIN, 2017, 18
- [2] Efficacy in high frequency migraine with aura prevention of a combination of Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium (Aurastop(C)) JOURNAL OF HEADACHE AND PAIN, 2018, 19
- [3] Comparison of the Effect of Tanacethum Parthenium, 5-Hydroxy Tryptophan, and Magnesium (Aurastop) versus Magnesium Alone on Aura Phenomenon and Its Evolution PAIN RESEARCH & MANAGEMENT, 2019, 2019
- [4] Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium (Aurastop(C)) efficacy in episodic migraine prevention. A multicentric observational study JOURNAL OF HEADACHE AND PAIN, 2017, 18
- [5] Efficacy in episodic migraine prevention of a combination of Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium (Aurastop(C)) A multicentric observational study JOURNAL OF HEADACHE AND PAIN, 2017, 18
- [6] Association of Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium ( Aurastop) versus Mg tablet impact on aura phenomena and its evolution : an observational study JOURNAL OF HEADACHE AND PAIN, 2018, 19
- [7] Association of Tanacethum Parthenium, 5-hydroxy tryptophan and magnesium (Aurastop) versus Mg tablet impact on aura phenomena and its evolution : an observational study JOURNAL OF HEADACHE AND PAIN, 2017, 18
- [8] Migraine aura treatment with the association of Tanacethum Parthenium, 5-Hydroxytryptophan and Magnesium (Aurastop®): an observational study JOURNAL OF HEADACHE AND PAIN, 2017, 18
- [9] Association of Tanacethum Parthenium, 5-Hydroxytryptophan and Magnesium (Aurastop®) in the treatment of migraine aura: an observational study JOURNAL OF HEADACHE AND PAIN, 2017, 18